DRTS
Alpha Tau Medical·NASDAQ
--
--(--)
--
--(--)
0.80 / 10
Underperform
The company's fundamental assessment is challenging, scoring only 0.8 out of 10. Key weaknesses include negative revenue-to-asset and profit margin ratios, despite a strong year-over-year revenue growth of 78.47%. The Net profit attributable to parent company shareholders to net profit ratio is 100%, indicating full profit allocation, but this is offset by poor asset turnover and negative earnings quality. Historical quartile analysis places most factors in lower-performing groups, reinforcing an underperform stance.
Analysis Checks(1/10)
Revenue-MV
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Net income-Revenue
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Current assets turnover ratio
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Net profit margin (%)
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
EBIT / Total operating revenue (%)
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Net profit / Total operating revenue (%)
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Revenue-MV
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Value-0.26
Score0/3
Weight9.21%
1M Return-2.92%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Net cash flow from operating activities / Operating revenue (%)
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Value-1513.77
Score0/3
Weight15.95%
1M Return-7.70%
Net income-Revenue
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.90%
1M Return-0.69%
Net profit margin (%)
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
Value-2972.64
Score0/3
Weight16.62%
1M Return-8.03%
Current assets turnover ratio
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
Value1.78
Score1/3
Weight4.63%
1M Return-1.72%
EBIT / Total operating revenue (%)
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Value-3056.43
Score0/3
Weight15.72%
1M Return-7.44%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit / Total operating revenue (%)
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Value-2164.14
Score0/3
Weight16.30%
1M Return-7.85%
Is DRTS undervalued or overvalued?
- DRTS scores 0.80/10 on fundamentals and holds a Premium valuation at present. Backed by its -43.48% ROE, 0.00% net margin, -15.17 P/E ratio, 7.81 P/B ratio, and -20.93% earnings growth, these metrics solidify its Underperform investment rating.
